Abstract
In an era of increasing medical costs and cries for health care reform in the United States, the pharmaceutical industry has come under intense scrutiny. Ethical issues are inherent in the pharmaceutical marketplace, and there is a need to address the moral rights and responsibilities of drug manufacturers consumers, health care professionals, and governmental agents in the production, distribution, regulation, and use of these products. A dual market system protecting individual rights to access and autonomy without placing an undue strain on societal resources would provide an adequate and equitable framework for an ethical pharmaceutical industry.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kreiner, A. The ethics of the pharmaceutical industry and the need for a dual market system. J Med Hum 16, 55–68 (1995). https://doi.org/10.1007/BF02276820
Issue Date:
DOI: https://doi.org/10.1007/BF02276820